New FDA Guidance Removes Interchangeability Statement from P

New FDA Guidance Removes Interchangeability Statement from Product Labels | Venable LLP

On September 18, 2023, the FDA issued a new draft guidance “Labeling for Biosimilar and Interchangeable Biosimilar Products,” updating the previous labeling guidance “Labeling for...

Related Keywords

April Breyer Menon , Additional Draftq As On Biosimilar Development , Interchangeable Biosimilar Products , Biosimilar Development , Full Prescribing Information ,

© 2025 Vimarsana